Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019

Introduction Coronavirus Disease 2019 (COVID‐19) has spread worldwide, and it has reached to more than 14.5 million cases. Although Hubei province is the epicenter of China, little is known about epidemiological and clinical features of COVID‐19 in other areas in Hubei province around Wuhan. In addi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The clinical respiratory journal 2020-11, Vol.14 (11), p.1067-1075
Hauptverfasser:	Hu, Fuying, Yin, Gang, Chen, Youping, Song, Jiangqin, Ye, Maosong, Liu, Jie, Chen, Cuicui, Song, Yuanlin, Tang, Xinjun, Zhang, Yong
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Adult Antiviral Agents - therapeutic use Antiviral drugs Betacoronavirus characteristics China - epidemiology Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronaviruses COVID-19 Disease transmission Female Hospitalization - statistics & numerical data Humans Immunoglobulins - therapeutic use Indoles - therapeutic use Interferons - therapeutic use Male Middle Aged Original Oseltamivir - therapeutic use Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Retrospective Studies Risk Factors SARS-CoV-2 Time Factors treatments viral shedding Virus Shedding - drug effects
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!